332 related articles for article (PubMed ID: 26991020)
1. Importance of margin width in breast-conserving treatment of early breast cancer.
Bodilsen A; Bjerre K; Offersen BV; Vahl P; Amby N; Dixon JM; Ejlertsen B; Overgaard J; Christiansen P
J Surg Oncol; 2016 May; 113(6):609-15. PubMed ID: 26991020
[TBL] [Abstract][Full Text] [Related]
2. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.
Freedman G; Fowble B; Hanlon A; Nicolaou N; Fein D; Hoffman J; Sigurdson E; Boraas M; Goldstein L
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1005-15. PubMed ID: 10421533
[TBL] [Abstract][Full Text] [Related]
3. Margin width and local recurrence after breast conserving surgery for ductal carcinoma in situ.
Ekatah GE; Turnbull AK; Arthur LM; Thomas J; Dodds C; Dixon JM
Eur J Surg Oncol; 2017 Nov; 43(11):2029-2035. PubMed ID: 28917445
[TBL] [Abstract][Full Text] [Related]
4. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
[TBL] [Abstract][Full Text] [Related]
5. The impact of age on the risk of ipsilateral breast tumor recurrence after breast-conserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation.
Ono Y; Yoshimura M; Hirata K; Yamauchi C; Toi M; Suzuki E; Takada M; Hiraoka M; Mizowaki T
Radiat Oncol; 2019 Jul; 14(1):121. PubMed ID: 31291997
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
7. Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival.
Vos EL; Siesling S; Baaijens MHA; Verhoef C; Jager A; Voogd AC; Koppert LB
Breast Cancer Res Treat; 2017 Jul; 164(1):157-167. PubMed ID: 28389735
[TBL] [Abstract][Full Text] [Related]
8. A study of margin width and local recurrence in breast conserving therapy for invasive breast cancer.
Dixon JM; Thomas J; Kerr GR; Williams LJ; Dodds C; Kunkler IH; Macaskill EJ
Eur J Surg Oncol; 2016 May; 42(5):657-64. PubMed ID: 26944365
[TBL] [Abstract][Full Text] [Related]
9. Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period.
Bosma SC; van der Leij F; van Werkhoven E; Bartelink H; Wesseling J; Linn S; Rutgers EJ; van de Vijver MJ; Elkhuizen PH
Breast Cancer Res Treat; 2016 Apr; 156(2):391-400. PubMed ID: 27008183
[TBL] [Abstract][Full Text] [Related]
10. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
[TBL] [Abstract][Full Text] [Related]
11. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
Jolly S; Kestin LL; Goldstein NS; Vicini FA
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
[TBL] [Abstract][Full Text] [Related]
12. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
[TBL] [Abstract][Full Text] [Related]
13. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ.
Dunne C; Burke JP; Morrow M; Kell MR
J Clin Oncol; 2009 Apr; 27(10):1615-20. PubMed ID: 19255332
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy.
Hwang N; Schiller DE; Crystal P; Maki E; McCready DR
Ann Surg Oncol; 2009 Nov; 16(11):3000-9. PubMed ID: 19603233
[TBL] [Abstract][Full Text] [Related]
16. Repeat lumpectomy for ipsilateral breast tumor recurrence after breast-conserving treatment.
Ishitobi M; Komoike Y; Nakahara S; Motomura K; Koyama H; Inaji H
Oncology; 2011; 81(5-6):381-6. PubMed ID: 22269927
[TBL] [Abstract][Full Text] [Related]
17. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.
Meric F; Mirza NQ; Vlastos G; Buchholz TA; Kuerer HM; Babiera GV; Singletary SE; Ross MI; Ames FC; Feig BW; Krishnamurthy S; Perkins GH; McNeese MD; Strom EA; Valero V; Hunt KK
Cancer; 2003 Feb; 97(4):926-33. PubMed ID: 12569592
[TBL] [Abstract][Full Text] [Related]
18. Margins in breast cancer: How much is enough?
Pilewskie M; Morrow M
Cancer; 2018 Apr; 124(7):1335-1341. PubMed ID: 29338088
[TBL] [Abstract][Full Text] [Related]
19. Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients.
Cambra MJ; Moreno F; Sanz X; Anglada L; Mollà M; Reyes V; Arenas M; Pedro A; Ballester R; García V; Casals J; Cusidó M; Jimenez C; Escribà JM; Macià M; Solé JM; Arcusa A; Seguí MA; Gonzalez S; Farrús B; Biete A
Clin Transl Oncol; 2020 May; 22(5):670-680. PubMed ID: 31264148
[TBL] [Abstract][Full Text] [Related]
20. No Ink on Ductal Carcinoma
Fregatti P; Gipponi M; Depaoli F; Murelli F; Guenzi M; Bonzano E; Ceppi M; Friedman D
Anticancer Res; 2019 Jan; 39(1):459-466. PubMed ID: 30591495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
